1 / 2
google
Details
- Product number
- 5800703
- CPT
- -
- Packaging group
- 120
- Unit
- Kapsel(n)
- Composition
- nilotinibum 50 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 39.025 mg, crospovidonum, poloxamerum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Articles (1)
Tasigna 50 mg, Kapseln
Kapseln
120
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
nilotinibum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
nilotinibi hydrochloridum monohydricum
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
39.025 MG | Substance | HBESI |
|
crospovidonum
|
- | Substance | HNIDK |
|
poloxamerum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
lacca
|
- | Substance | HNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
propylenglycolum
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
ammoniae solutio 28 per centum
|
- | Substance | HNIDK |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 58007
- Drug name
- Tasigna, Kapseln
- Galenic form
- KAHA
- ATC Code
- L01EA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/07/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TASIGNA caps 50 mg 120 pce
- Description (DE)
- TASIGNA Kaps 50 mg 120 Stk
- Market launch
- 31/01/2018
- Narcotic (BTM)
- No